North America Radioactive Tracer Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others)

No. of Pages: 112    |    Report Code: BMIRE00029121    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Radioactive Tracer Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Radioactive Tracer Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Radioactive Tracer Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Prevalence of Chronic Diseases
  • 5.1.2 Increased Use of Nuclear Imaging Techniques
5.2 Market Opportunities
  • 5.2.1 Use of Radioactive Tracers in Cancer Diagnosis
5.3 Future Trends
  • 5.3.1 Short Shelf-Life of Radioactive Tracers
  • 5.3.2 Availability of Substitutes to Nuclear Diagnosti Imaging Procedures
5.4 Impact of Drivers and Restraints

6. North America Radioactive Tracer Market Regional Analysis

6.1 North America Radioactive Tracer Market Overview
6.2 North America Radioactive Tracer Market Revenue 2020-2030 (US$ Million)
6.3 North America Radioactive Tracer Market Forecast Analysis

7. North America Radioactive Tracer Market Analysis – by Tracer Type

7.1 Technetium-99m & Tc-97m
  • 7.1.1 Overview
  • 7.1.2 Technetium-99m & Tc-97m: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Iodine-131
  • 7.2.1 Overview
  • 7.2.2 Iodine-131: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Iron-59
  • 7.3.1 Overview
  • 7.3.2 Iron-59: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Lutetium-171
  • 7.4.1 Overview
  • 7.4.2 Lutetium-171: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Rubidium Chloride & Ammonia
  • 7.5.1 Overview
  • 7.5.2 Rubidium Chloride & Ammonia: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Scandium-46
  • 7.6.1 Overview
  • 7.6.2 Scandium-46: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Seaborgium-269
  • 7.7.1 Overview
  • 7.7.2 Seaborgium-269: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Hassium-269
  • 7.8.1 Overview
  • 7.8.2 Hassium-269: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Gallium Citrate Ga 67
  • 7.9.1 Overview
  • 7.9.2 Gallium Citrate Ga 67: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.10 Prostate-Specific Membrane Antigen
  • 7.10.1 Overview
  • 7.10.2 Prostate-Specific Membrane Antigen: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.11 FDDNP & FDOPA
  • 7.11.1 Overview
  • 7.11.2 FDDNP & FDOPA: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.12 Phosphorus-32 & Chromium-51
  • 7.12.1 Overview
  • 7.12.2 Phosphorus-32 & Chromium-51: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.13 Thallium-201
  • 7.13.1 Overview
  • 7.13.2 Thallium-201: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.14 F-18 FDG
  • 7.14.1 Overview
  • 7.14.2 F-18 FDG: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.15 F-18 FAPI
  • 7.15.1 Overview
  • 7.15.2 F-18 FAPI: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.16 Ga-68 FAPI
  • 7.16.1 Overview
  • 7.16.2 Ga-68 FAPI: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.17 F-18 PSMA
  • 7.17.1 Overview
  • 7.17.2 F-18 PSMA: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.18 DOTATOC/DOTANOC/DOTATATE
  • 7.18.1 Overview
  • 7.18.2 DOTATOC/DOTANOC/DOTATATE: North America Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Radioactive Tracer Market Analysis – by Test Type

8.1 PET
  • 8.1.1 Overview
  • 8.1.2 PET: North America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.2 SPECT
  • 8.2.1 Overview
  • 8.2.2 SPECT: North America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Radioactive Tracer Market Analysis – by Application

9.1 Oncology
  • 9.1.1 Overview
  • 9.1.2 SPECT: North America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Pulmonary
  • 9.2.1 Overview
  • 9.2.2 SPECT: North America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Neurology
  • 9.3.1 Overview
  • 9.3.2 SPECT: North America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiology
  • 9.4.1 Overview
  • 9.4.2 SPECT: North America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Radioactive Tracer Market – North America Analysis

10.1 North America
  • 10.1.1 North America Radioactive Tracer Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 North America Radioactive Tracer Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 US: North America Radioactive Tracer Market Breakdown, by Tracer Type
    • 10.1.1.1.2 US: North America Radioactive Tracer Market Breakdown, by Test Type
    • 10.1.1.1.3 US: North America Radioactive Tracer Market Breakdown, by Application
  • 10.1.1.2 Canada: North America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Canada: North America Radioactive Tracer Market Breakdown, by Tracer Type
    • 10.1.1.2.2 Canada: North America Radioactive Tracer Market Breakdown, by Test Type
    • 10.1.1.2.3 Canada: North America Radioactive Tracer Market Breakdown, by Application
  • 10.1.1.3 Mexico : North America Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Radioactive Tracer Market Breakdown, by Tracer Type
    • 10.1.1.3.2 Mexico : North America Radioactive Tracer Market Breakdown, by Test Type
    • 10.1.1.3.3 Mexico : North America Radioactive Tracer Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Radioactive Tracer Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Rotem Industries Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Invicro LLC
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Cardinal Health Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Newcastle University
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Novartis AG
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Curium
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Blue Earth Diagnostics Limited
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 General Electric Co
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 IBA Radiopharma Solutions
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Radioactive Tracer Market

  1. Rotem Industries Ltd
  2. Invicro LLC
  3. Cardinal Health Inc
  4. Newcastle University
  5. Novartis AG
  6. Curium
  7. Blue Earth Diagnostics Limited
  8. General Electric Co
  9. IBA Radiopharma Solutions
north-america-radioactive-tracer-market